For individuals with T1D, hypoglycemia is the most common acute side effect of insulin therapy and serves as one of the major barriers to optimal glycaemic control, presenting a significant challenge for children and their parents in attempting to achieve optimal management of blood glucose levels [23]. This evidence concerns the gene INS and Hypoglycemia.